F. Liu and G. Rabinovich, Galectins as modulators of tumour progression, Nature Reviews Cancer, vol.19, issue.1, pp.29-41, 2005.
DOI : 10.1038/nrc1275

S. Bektas, B. Bahadir, B. Ucan, and S. Ozdamar, CD24 and Galectin-1 Expressions in Gastric Adenocarcinoma and Clinicopathologic Significance, Pathology & Oncology Research, vol.33, issue.4, pp.569-577, 2010.
DOI : 10.1007/s12253-010-9248-8

A. Gomez-brouchet, F. Mourcin, P. Gourraud, C. Bouvier, D. Pinieux et al., Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma, Human Pathology, vol.41, issue.9, p.20399482, 2010.
DOI : 10.1016/j.humpath.2009.10.028
URL : https://hal.archives-ouvertes.fr/hal-00507297

E. Jung, H. Moon, B. Cho, C. Jeong, and Y. Joo, Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer, International Journal of Cancer, vol.7, issue.11, pp.2331-2338, 2007.
DOI : 10.1002/ijc.22434

N. Oka, Y. Takenaka, and A. Raz, Galectins and urological cancer, Journal of Cellular Biochemistry, vol.300, issue.1, pp.118-124, 2004.
DOI : 10.1002/jcb.10663

F. Orlandi, E. Saggiorato, G. Pivano, B. Puligheddu, and A. Termine, Galectin-3 is a presurgical marker of human thyroid carcinoma, Cancer Res, vol.58, pp.3015-3020, 1998.

C. Tang, T. Tan, C. Li, Z. Chen, and L. Ruan, Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis, Oncol Rep, vol.24, pp.495-500, 2010.

M. Mayoral, C. Mayoral, A. Meneses, L. Villalvazo, and A. Guzman, Identification of Galectin-3 and Mucin-Type O-Glycans in Breast Cancer and Its Metastasis to Brain, Cancer Investigation, vol.61, issue.6, pp.615-623, 2008.
DOI : 10.1016/j.chembiol.2004.05.009

G. Gendronneau, S. Sidhu, D. Delacour, T. Dang, and C. Calonne, Galectin-7 in the Control of Epidermal Homeostasis after Injury, Molecular Biology of the Cell, vol.19, issue.12, pp.5541-5549, 2008.
DOI : 10.1091/mbc.E08-02-0166
URL : https://hal.archives-ouvertes.fr/hal-00326943

T. Magnaldo, D. Fowlis, and M. Darmon, Galectin-7, a marker of all types of stratified epithelia, Differentiation, vol.63, issue.3, p.9697310, 1998.
DOI : 10.1046/j.1432-0436.1998.6330159.x

S. Saussez and R. Kiss, Galectin-7, Cellular and Molecular Life Sciences, vol.63, issue.6, pp.686-697, 2006.
DOI : 10.1007/s00018-005-5458-8

M. Demers, A. Rose, A. Grosset, K. Biron-pain, and L. Gaboury, Overexpression of Galectin-7, A Myoepithelial Cell Marker, Enhances Spontaneous Metastasis of Breast Cancer Cells, The American Journal of Pathology, vol.176, issue.6, p.20382700, 2010.
DOI : 10.2353/ajpath.2010.090876
URL : https://hal.archives-ouvertes.fr/pasteur-00819591

C. Perou, T. Sørlie, M. Eisen, M. Van-de-rijn, and S. Jeffrey, Molecular portraits of human breast tumours, Nature, vol.406, issue.6797, pp.747-752, 2000.
DOI : 10.1038/35021093

T. Takata, Y. Ishigaki, T. Shimasaki, H. Tsuchida, and Y. Motoo, Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro, Oncol Rep, vol.28, pp.1968-1976, 2012.

X. Zhu, M. Ding, M. Yu, M. Feng, and L. Tan, Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis, BMC Cancer, vol.13, issue.2, p.20546628, 2010.
DOI : 10.1038/sj.onc.1206631

S. Saussez, C. Decaestecker, F. Lorfevre, C. D. Mortuaire, and G. , Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas, Histopathology, vol.27, issue.4, pp.483-493, 2008.
DOI : 10.1016/j.bmcl.2006.10.069

Y. St-pierre, C. Campion, and A. Grosset, A distinctive role for galectin-7 in cancer ?, Frontiers in Bioscience, vol.17, issue.1, pp.438-45010, 2012.
DOI : 10.2741/3937
URL : https://hal.archives-ouvertes.fr/pasteur-01009758

K. Polyak, Y. Xia, J. Zweier, K. Kinzler, and B. Vogelstein, A model for p53-induced apoptosis, Nature, vol.389, issue.6648, pp.300-305, 1997.
DOI : 10.1038/38525

F. Bernerd, A. Sarasin, and T. Magnaldo, Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes, Proceedings of the National Academy of Sciences, vol.96, issue.20, pp.11329-11334, 1999.
DOI : 10.1073/pnas.96.20.11329

A. Mourskaia, Z. Dong, S. Ng, M. Banville, and J. Zwaagstra, Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone, Oncogene, vol.28, 2009.

S. Baker, S. Markowitz, E. Fearon, J. Willson, and B. Vogelstein, Suppression of human colorectal carcinoma cell growth by wild-type p53, Science, vol.249, issue.4971, p.2144057, 1990.
DOI : 10.1126/science.2144057

T. Brummelkamp, R. Bernards, and R. Agami, A System for Stable Expression of Short Interfering RNAs in Mammalian Cells, Science, vol.296, issue.5567, pp.550-553, 2002.
DOI : 10.1126/science.1068999

C. Villeneuve, L. Baricault, L. Canelle, N. Barboule, and C. Racca, Mitochondrial proteomic approach reveals galectin-7 as a novel BCL-2 binding protein in human cells, Molecular Biology of the Cell, vol.22, issue.7, pp.10-16, 2011.
DOI : 10.1091/mbc.E10-06-0534

A. Petitjean, M. Achatz, A. Borresen-dale, P. Hainaut, and M. Olivier, TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes, Oncogene, vol.47, issue.15, 2007.
DOI : 10.1158/1078-0432.CCR-05-0507

I. Kuwabara, Y. Kuwabara, R. Yang, M. Schuler, and D. Green, Galectin-7 (PIG1) Exhibits Pro-apoptotic Function through JNK Activation and Mitochondrial Cytochrome cRelease, Journal of Biological Chemistry, vol.277, issue.5, pp.3487-3497, 2002.
DOI : 10.1074/jbc.M109360200

S. Cho, S. Park, M. Kwon, T. Jeong, and S. Bok, Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage, Mol Cell Biochem, vol.243, 2003.

K. Natarajan, S. Singh, T. Burke, . Jr, D. Grunberger et al., Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B., Proceedings of the National Academy of Sciences, vol.93, issue.17, 1996.
DOI : 10.1073/pnas.93.17.9090

M. Scian, K. Stagliano, M. Anderson, S. Hassan, and M. Bowman, Tumor-derived p53 mutants induce NF-kappaB2 gene expression, Mol Cell Biol, vol.25, p.16260623, 2005.
DOI : 10.1128/mcb.25.22.10097-10110.2005
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1280285

L. Weisz, A. Damalas, M. Liontos, P. Karakaidos, and G. Fontemaggi, Mutant p53 Enhances Nuclear Factor ??B Activation by Tumor Necrosis Factor ?? in Cancer Cells, Cancer Research, vol.67, issue.6, pp.2396-2401, 2007.
DOI : 10.1158/0008-5472.CAN-06-2425

G. Schneider, A. Henrich, G. Greiner, V. Wolf, and A. Lovas, Cross talk between stimulated NF-??B and the tumor suppressor p53, Oncogene, vol.269, issue.19, pp.2795-2806, 2010.
DOI : 10.1073/pnas.0813088106

M. Karin, Nuclear factor-??B in cancer development and progression, Nature, vol.12, issue.7092, pp.431-436, 2006.
DOI : 10.1038/nature04870

F. Bidard, R. Conforti, T. Boulet, S. Michiels, and S. Delaloge, Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers, Annals of Oncology, vol.18, issue.7, pp.1285-1286, 2007.
DOI : 10.1093/annonc/mdm360

A. Joerger and A. Fersht, Structural Biology of the Tumor Suppressor p53, Annual Review of Biochemistry, vol.77, issue.1, pp.557-582, 2008.
DOI : 10.1146/annurev.biochem.77.060806.091238

T. Lehman, R. Modali, P. Boukamp, J. Stanek, and W. Bennett, p53 Mutations in human immortalized epithelial cell lines, Carcinogenesis, vol.14, issue.5, pp.833-839, 1993.
DOI : 10.1093/carcin/14.5.833

A. Bullock, J. Henckel, and A. Fersht, Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy, Oncogene, vol.19, issue.10, pp.1245-1256, 2000.
DOI : 10.1038/sj.onc.1203434

P. Hainaut and M. Hollstein, p53 and Human Cancer: The First Ten Thousand Mutations, Adv Cancer Res, vol.77, pp.81-137, 2000.
DOI : 10.1016/S0065-230X(08)60785-X